New Two-Step attack on deadly melanoma brain tumors

NCT ID NCT06887088

Summary

This study is testing a two-step treatment for people with advanced melanoma that has spread to the brain and is causing symptoms. First, patients take two pills (encorafenib and binimetinib) for about two months. Then, they receive two intravenous drugs (cemiplimab and fianlimab) for up to two years. The main goal is to see if this approach can stop the brain tumors from growing for at least 6 months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA BRAF V600E/K MUTATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinico Universitario Virgen de la Arrixaca

    RECRUITING

    Murcia, Murcia, 30120, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Complejo Hospitalario Universitario A Coruña

    RECRUITING

    A Coruña, A Coruña, 15006, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital Clinico San Carlos

    RECRUITING

    Madrid, Madrid, 28040, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Clínic de Barcelona

    RECRUITING

    Barcelona, Barcelona, 08036, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Clínico Universitario Valencia.

    RECRUITING

    Valencia, Valencia, 46010, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46014, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Regional Universitario de Málaga

    RECRUITING

    Málaga, Málaga, 29010, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario Gregorio Marañon

    NOT_YET_RECRUITING

    Madrid, Madrid, 28007, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario Marqués de Valdecilla

    RECRUITING

    Santander, Cantabria, 39008, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario Puerta del Hierro

    RECRUITING

    Majadahonda, Madrid, 28222, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, Madrid, 28034, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario San Pedro de Alcántara

    RECRUITING

    Cáceres, Cáceres, 10003, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario Vall d´Hebron

    RECRUITING

    Barcelona, Barcelona, 08035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Universitario de Burgos

    RECRUITING

    Burgos, Burgos, 09006, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Virgen de la Macarena (Sevilla)

    RECRUITING

    Seville, Sevilla, 41009, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Instituto Catalán de Oncología - Hospital Duran i Reynals

    RECRUITING

    Barcelona, Barcelona, 08908, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Onkologikoa (Donostia)

    RECRUITING

    Donostia / San Sebastian, Donostia, 20014, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Quiron Dexeus - IOR

    RECRUITING

    Barcelona, Barcelona, 08028, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.